A cost model for complications in diabetes type II patients

• At: Beijing (China) (2007)
• Type: Presentation
• By: HARTZEMA, Abraham (University of Florida, Gainesville, United States of America)
• Co-author(s): Winterstein, Almut (University of Florida, Gainesville, United States of America)
  Segal, Rich (University of Florida, Gainesville, United States of America)
  Snedecor, Sonya (Pharmetrics, Washington, United States of America)
  
• Abstract:

  Diabetes mellitus, a disease increasing in prevalence, if left uncontrolled leads to debilitating complications, including renal failure and blindness. Glycosylated hemoglobin (HbA1c), an indicator of glycemic control over a 3-month time period, is the preferred measure for determining whether a diabetic is controlled. The level of glycemic

  ..

The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login